Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sally-Anne Vincent

BSc, MSc

Research Assistant

I am a Research Assistant in the SINAPPS Research Group (PPiP2/SINAPPS2), primarily working on the SINAPPS2 Clinical Trial. PPiP2 is a prevalence study looking at neuronal cell antibodies in psychosis. SINAPPS2 is a randomised phase II double-blinded placebo-controlled trial designed to see whether immunotherapy (IVIG and Rituximab) is an effective treatment for psychosis in people with neuronal cell antibodies. I am based at the Department of Psychiatry, University of Oxford. I am involved in recruitment and follow ups for SINAPPS2 and supporting the South and South-West of England in recruitment and meeting their allocated targets in the PPiP2 study.

Previously, whilst working at the Institute of Psychiatry, I was involved in research that aimed to establish whether or not there was a link between a person’s genetic make-up and their response to drug therapy.

I have a BSc Psychology and MSc Cognitive Neuroscience which I obtained from the University of Reading.